Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Healthtrust
QuintilesIMS
US Army
Daiichi Sankyo
US Department of Justice
Teva
Julphar

Generated: February 18, 2019

DrugPatentWatch Database Preview

Drug Price Trends for ALOGLIPTIN

« Back to Dashboard

Drug Price Trends for ALOGLIPTIN

Average Pharmacy Cost for ALOGLIPTIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALOGLIPTIN 12.5 MG TABLET 45802-0103-65 5.45904 EACH 2019-01-23
ALOGLIPTIN-METFORMIN 12.5-1000 45802-0211-72 2.59209 EACH 2019-01-23
ALOGLIPTIN 25 MG TABLET 45802-0150-65 5.43780 EACH 2019-01-23
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for ALOGLIPTIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
OSENI/ALOGLIPTIN 25MG/PIOGLITAZONE 15MG Perrigo Sourcing Solutions, Inc. 45802-0351-65 30 84.68 2019-01-01 - 2023-09-30 FSS
KAZANO/ALOGLIPTIN BENZOATE 12.5MG/METF500MG Perrigo Sourcing Solutions, Inc. 45802-0169-72 60 89.99 2019-01-01 - 2023-09-30 FSS
OSENI/ALOGLIPTIN 25MG/PIOGLITAZONE 30MG Perrigo Sourcing Solutions, Inc. 45802-0402-65 30 92.66 3.08867 EACH 2018-10-01 - 2023-09-30 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Cipla
Merck
UBS
AstraZeneca
Teva
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.